BioCentury
ARTICLE | Clinical News

Lefamulin: Completed Ph III enrollment

April 13, 2017 11:13 PM UTC

Nabriva completed enrollment of 550 patients in the double-blind, international Phase III LEAP 1 trial comparing IV and oral lefamulin vs. IV and oral moxifloxacin with or without Zyvox linezolid for ...

BCIQ Company Profiles

Nabriva Therapeutics plc

BCIQ Target Profiles

Ribosomal 50S subunit